Twin Focus Capital Partners’s Medicines Co MDCO Stock Holding History

Twin Focus Capital Partners’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-26,000	Closed	-$856K	–	111
2018 Q1	$856K	Hold	26,000	–	–	0.43%	44
2017 Q4	$711K	Hold	26,000	–	–	0.36%	47
2017 Q3	$963K	Hold	26,000	–	–	0.5%	43
2017 Q2	$988K	Hold	26,000	–	–	0.54%	39
2017 Q1	$1.27M	Hold	26,000	–	–	0.76%	29
2016 Q4	$882K	Hold	26,000	–	–	0.57%	39
2016 Q3	$981K	Hold	26,000	–	–	0.68%	34
2016 Q2	$874K	Hold	26,000	–	–	0.69%	37
2016 Q1	$826K	Hold	26,000	–	–	0.78%	33
2015 Q4	$971K	Buy	+26,000	New	+$983K	0.98%	27

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Twin Focus Capital Partners's MDCO Position: Q2 2018 in Review

Twin Focus Capital Partners sold out of Medicines Co (MDCO) in Q2 2018, closing a stake of 26,000 shares — an estimated $856K sold.

Twin Focus Capital Partners first reported a position in MDCO in Q4 2015 and held it in 10 quarters. The position peaked at $1.27M in Q1 2017. 188 funds tracked by Wall St. Rank hold MDCO as of Q2 2018.

Twin Focus Capital Partners reported no remaining Medicines Co position as of Q2 2018 after selling out during the quarter.
Twin Focus Capital Partners sold 26,000 Medicines Co shares in Q2 2018, an estimated $856K.
Twin Focus Capital Partners first reported a position in Medicines Co in Q4 2015 and held it in 10 quarters.
Twin Focus Capital Partners's Medicines Co position peaked at $1.27M in Q1 2017.
188 funds tracked by Wall St. Rank held Medicines Co as of Q2 2018.

Based on Twin Focus Capital Partners's 13F filing for Q2 2018, filed 10 Aug 2018.